{"name":"DiscGenics, Inc.","slug":"discgenics-inc","ticker":"","exchange":"","domain":"discgenics.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"IDCT","genericName":"IDCT","slug":"idct","indication":"Other","status":"phase_1"},{"name":"IDCT (rebonuputemcel)","genericName":"IDCT (rebonuputemcel)","slug":"idct-rebonuputemcel","indication":"Degenerative disc disease of the lumbar spine","status":"phase_3"}]}],"pipeline":[{"name":"IDCT","genericName":"IDCT","slug":"idct","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""},{"name":"IDCT (rebonuputemcel)","genericName":"IDCT (rebonuputemcel)","slug":"idct-rebonuputemcel","phase":"phase_3","mechanism":"IDCT (rebonuputemcel) is an allogeneic juvenile chondrocyte cell therapy designed to regenerate cartilage and restore joint function in degenerative disc disease.","indications":["Degenerative disc disease of the lumbar spine"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwJBVV95cUxOZDdBS25CZmxzbHE3WUVDSW5hMmFLZ01GcDJVM0tUeEVFS1pNSEtUU3lxSzdzSlZnblJlSmZVT2dzaDFUVWlZOU9HM0pHWVhfQ0kwNG9qSFIzY3dUcjJSa19sZGRSWkVnaDVoNHNqTnpEdHlMVTZtLUhEbWNvaUVTQnBBMVgtWFNTYkVKdXpSLWduOTl0bUYyYnFLMlloZHFLVXBVakFrdFptQnZjY1pWNWlqdkI5eFN1YWlvS1lSVzlpeHVqYmg4TVJEOE1STG4tNHpWUlMydFl1NFRNM1paUjZUUkc5cHd3MzZSNjNvNHdWTENlOGRKMktWck1fdi1iSXNpaHVHV2t4Y1Y0dkFvVy11SmNoMHBzRWtKWV9SenJLdjBQb2xr?oc=5","date":"2025-04-09","type":"trial","source":"PR Newswire","summary":"Peer-Reviewed Article Reporting DiscGenics' Cell Therapy Phase I/II Study Results Receives International Journal of Spine Surgery Best Paper Award - PR Newswire","headline":"Peer-Reviewed Article Reporting DiscGenics' Cell Therapy Phase I/II Study Results Receives International Journal of Spin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxNanhkcThHQWF5VGRBbWV5eG1DSldSNm1tRmQtZ09acEtid1lQb3lOdHFGMkFzeGZiQzkzV2hmVTNjMHd0S3BrMlVweWExalk1TWx5c0NFODI2TFBuVDRZbTdRaEdoTXhJTTdSWnE3ZlFUSl9HOHRRWHhwZWppbXdfdlJYUFV1Mm5vdzJZcUprbmNjME9jMnFzakJyejFoNG9HekNFcmRzMURmV2JzNVozZndTSVE5ZzU1eDJMdDI5RTZDZmdmMXZMUnBUVnVOYl8zeGZVOFRTdExnUEl2SlFwTE10bk9yOFlhWUl6T0VaUEwtc29nU25KS2tkTGlTbjlkLTNYS0xHYXlWSFJfMnpqalp4SFk?oc=5","date":"2024-07-23","type":"regulatory","source":"BioPharma APAC","summary":"DiscGenics Receives FDA Approval to Proceed with Phase III Clinical Trials for Regenerative Cell Therapy for Lumbar Degenerative Disc Disease - BioPharma APAC","headline":"DiscGenics Receives FDA Approval to Proceed with Phase III Clinical Trials for Regenerative Cell Therapy for Lumbar Dege","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi3gJBVV95cUxPa2pqZWlBakVSVUNsUUtST29EMTJMZjY1WG9YMHdRU0RTVWdZa1duWm80WFc0dnprbFZUczBtTlVWQ3k3TDFiZlczc3BheThuMnQ2MUVWTnk4dFZWTlluZHpmZXI1clA1LXNick03OFh1X1Q1VFNYZlB1R1JYX1FBVnBkVG1INmwtQTVxQXpLdXE1QzlGY21La2NUYzJySTNkNlZ1ZW1hVm1xQWtJRF9BamZXV2c2OWhxYXJ3bEswR3luNkZKQWdrRjFrMXNyMkI5NXQ1T245b1hIZTNaRWdMZ3FjZVI3UzVnQ3VfNGl6bERYZUE2dkZ3bUJJZlp1VjRmcVBFTFJZOHd0ZnZmTFlFNXhTTDV1Q3NhYkVCMkViMFpmaHFaQkRTYllxWTJjZVJLWVUyRFVqZ1R3QUlIaHd6T3h2b29lNWVpNl9jWU5TNmVncjJUV29OaHllUU1QUQ?oc=5","date":"2024-07-16","type":"regulatory","source":"PR Newswire","summary":"DiscGenics Announces US FDA Approval to Proceed with Phase III Clinical Evaluation of Allogeneic, Injectable Disc Progenitor Cell Therapy for Symptomatic Lumbar Degenerative Disc Disease - PR Newswire","headline":"DiscGenics Announces US FDA Approval to Proceed with Phase III Clinical Evaluation of Allogeneic, Injectable Disc Progen","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2024-07-09","type":"regulatory","source":"PR Newswire","summary":"DiscGenics Announces the International Journal of Spine Surgery Has Published Results from an FDA-Approved Study of an Allogeneic Disc Progenitor Cell Therapy for the Treatment of Adults with Lumbar D","headline":"DiscGenics Announces the International Journal of Spine Surgery Has Published Results from an FDA-Approved Study of an A","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMijwJBVV95cUxPVTRpT1Y5WGJ2c0lYNkpBZl9ISHRqd1hHN2lGNy0tZV9kZDZjQUh4eXlkWjFLR09vMjJ0M0tlbm5BQjVqT09GU1BwZFJfeUc2VU1lMGQ3bG45VmY3cldfeUplNXRlN3JfRUsyYlI0Y082bzdpa3JOcEh5ZGRrbVpaV0R6Z1pFYlhDWm1ZckUzV2hVYVliRVkwTXFNdWplWVZXNzNvTHZzWlEwWXdVaGRrbUc3VG5sZ0xvMzRuVzVfTVczazRTYko4a0RKOWtnQXlzR25lRnRoUlpmZTJZMVdFal92ZGhPUC0tM19VNWlKdmRVcjNGWExrME1zSDhnWjBoeEVYYVRnLTBqNFBDOWtF?oc=5","date":"2023-01-26","type":"regulatory","source":"PR Newswire","summary":"DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc Disease - PR Newswire","headline":"DiscGenics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to IDCT for Degenerative Disc","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgJBVV95cUxNY0xhREdnVWV6U0dzdFJ3cGZiVGlJX3RSRWFSM2E2YUlvcWRtV0wzZzF5c1lhWWVzUHpZVlN4b0ZlTWN4bERIdkg4TnZOazE3d01XRm93bV9wdEx5ZVZaQ18zUHBKSDhIVTBVYnhicHc0N2VGRC1TV2kxR2ZlMWdQSmhvZmlyTXB1bjhDbTl6cDNQcHJhc0lwTFV0YmRRU0JZTnNraU1iLXhmTnJnLW45OGRXbWV4TlpnQThtSE9wU3RIQm84QVVWdlNvbnlkdnRTSFBGV1JRV0hrUDJUeUhFV0QxLUdQTW1hTlBLblcwLXFlTHdWa3E1T2xGQWFYRWt2by13OXRJZ3RCaHh1Uk04Y1BkbnV6dw?oc=5","date":"2023-01-23","type":"trial","source":"PR Newswire","summary":"DiscGenics Announces Positive Two-Year Clinical Data from Study of Discogenic Progenitor Cell Therapy for Degenerative Disc Disease - PR Newswire","headline":"DiscGenics Announces Positive Two-Year Clinical Data from Study of Discogenic Progenitor Cell Therapy for Degenerative D","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxOZzhwSDBuSmJ5RnFFZlNkZ2tGYUs2UDRxd0lhTngzczNnS29uMlJIZnBNZVBTelE2eVRsSDVBR0hzWXpkY0xnemZQOW85Y25NakRxeG5CclVLaGFjdXF1TXNyU0l5UHJDeUt0MkFhNVdNOEZkZVVTTkJUUWRGZy1tSVMxRzE4R1dzNTJySFlfMXJIcmQ3OGttMnVBNGVTTXJkM0hLZnJ5QQ?oc=5","date":"2020-08-25","type":"pipeline","source":"PR Newswire","summary":"DiscGenics Raises $50 Million in Series C Funding - PR Newswire","headline":"DiscGenics Raises $50 Million in Series C Funding","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxQTTZBTXhlVW9CY3o1ZmVCbkpNRnRTZGU1VkZtNEt5RHpZUkhna19JTlFDbENPS1ppSERWMzBveUtHRU9oYkNEMTVCdVA2RXlqbldIV1VzXzVsYlBZN2FPQ2lhX1ZNN2dqem5JU0dUaWlXMm11SjFJbzNjNUtVMHV0eFFGdWZ6SlRVbU1KQkwzUXZlSmJZMTVSdDBFTkRoNnFzOGp4Tk50MVpPY2tNU2prc3Y2VVhMYlZ4dHVaRnFDeEdBVjhhX2l5STB4cTd6Rk5NOXpHSjM2OGdlcHlQYzdTTFZVd0l5anV3MVZTa3pSQS11SHRFc0hZMEJDc3pCXzd3bVE?oc=5","date":"2019-08-07","type":"trial","source":"PR Newswire","summary":"DiscGenics Announces First Patients Treated in Japanese Clinical Trial of Cell Therapy for Degenerative Disc Disease - PR Newswire","headline":"DiscGenics Announces First Patients Treated in Japanese Clinical Trial of Cell Therapy for Degenerative Disc Disease","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AJBVV95cUxNSjBSbC1vSjNqbUVtQ1RaZlZUUVo2LWx0TWpuZlEtRE15cUJ5bVNCYjBpYktqaERlcF9ER2tVSkpCTVVzMjlHbE5fangzWk92WGRTSEtRZ2Y4ZkQ2OWdfQXk4eTFsZmhIdGNhY1dzZEEwaDk3amZGbEVpaEVWYzBBRHMtbVV5NUt3a2lQTGZfaGFOdUxCN0NJTnRZOGlWTDhScFhKbnFLVy16VlVjaW1OZThiY085aE1Jd2ZZOFJ2N2g2T2xCbl9IZlpGNGoyQ1AwblJ2c2wycHN1Sm0tV0ljT1Jmak5wS0l1ajFJQTQxdHhLU0FRWjJ4cVMyUjE3aElvZnVGV0NLN3BXNjhWU3BhOU45V2NHaGctajdwVkdTWVRXQmJ1RzRNbUxPb3ZwcW0wOGJ5ajIwcDl5UEpRSzllVkIwb0NMdTJJZlRiWHhUWGg?oc=5","date":"2018-12-11","type":"regulatory","source":"PR Newswire","summary":"DiscGenics Receives Approval from Japanese Pharmaceuticals and Medical Devices Agency to Begin Clinical Evaluation of Non-Surgical Degenerative Disc Disease Treatment in Japan - PR Newswire","headline":"DiscGenics Receives Approval from Japanese Pharmaceuticals and Medical Devices Agency to Begin Clinical Evaluation of No","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxPNkt0dDRrS0VpMU1BRVhCeF9ndXVXNnNnc2tHZGJpT2dvT0tfdTZfS0xSTGpidE44S1k4UURQWnNtX3V3YldUdHpOaEUyc1ozRHJpZk14SUc3ZC1BTXluVUlLVS1wR3VZVk9qVE5zdVdReVhXd01tRHd2YmlkblRBVW9iLWtaWHItVmRTZElQX1JXRkdoc0F4Z2dzWDhSVl84YmlIVXVzMGdsbzJRQXFiWmpueW5oanhnOTNxQ1A5eWF3X3RVcWdvQmVCTXhwOHBiUF9hWTZrbEVZQ0hoUGFSeUdLcWZFWnYyNzR1Ulp3?oc=5","date":"2018-04-26","type":"trial","source":"PR Newswire","summary":"DiscGenics Announces First Patient Treated in U.S. Clinical Trial of IDCT for Degenerative Disc Disease - PR Newswire","headline":"DiscGenics Announces First Patient Treated in U.S. Clinical Trial of IDCT for Degenerative Disc Disease","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_1":1,"phase_3":1},"enrichmentLevel":0,"visitCount":6,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}